G01N 2333/96444
Factor x
Official title: Factor X (3.4.21.6)
G01N2333/96444 (Factor x) appears on 68 US grants and 53 published applications in this corpus.
Search patents in G01N- Granted patents
- 68
- Published applications
- 53
- Assignees
- 63
- Inventors
- 145
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 2 | 3 |
| 2006 | 3 | 0 |
| 2007 | 2 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 1 | 2 |
| 2015 | 3 | 3 |
| 2016 | 2 | 6 |
| 2017 | 2 | 1 |
| 2018 | 2 | 2 |
| 2019 | 3 | 4 |
| 2020 | 0 | 4 |
| 2021 | 3 | 2 |
| 2022 | 1 | 5 |
| 2023 | 2 | 1 |
| 2024 | 0 | 0 |
| 2025 | 2 | 2 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating intracranial hemorrhage and assessing efficacy21 Jul 2026US 12,685,763 B2Alexion Pharmaceuticals, Inc.
- Fluid property measurement devices and methods24 Mar 2026US 12,584,930 B2Abram Scientific, Inc.
- Method for detecting bi-specific antibody complex9 Dec 2025US 12,493,033 B2Chugai Seiyaku Kabushiki Kaisha
- Method for detecting the presence, identification and quantification in a blood sample of anticoagulants which are blood coagulation enzymes inhibitors, and means for the implementation thereof18 Nov 2025US 12,473,584 B2Diagnostica Stago
- Identification of anticoagulants in a sample19 Dec 2023US 11,846,640 B2Pentapharm AG
- Method for potency determination of haina polysaccharide (hps)10 Sep 2026US 2026/0266853 A1Harbin Hongdoushan Bio-Pharm Co., Ltd.
- Method for detecting the presence, identification and quantification in a blood sample of anticoagulants which are blood coagulation enzymes inhibitors, and means for the implementation thereof12 Mar 2026US 2026/0071253 A1Diagnostica Stago
- Method for excluding factor xia inhibitors in patient samples5 Mar 2026US 2026/0063650 A1Siemens Healthcare Diagnostics Products GmbH
- Compounds for the detection and inhibition of coagulation proteases26 Jun 2025US 2025/0208137 A1Cambridge Enterprise Limited
- Compositions and methods for diagnosing and/or treating chronic kidney disease30 Jan 2025US 2025/0035648 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Method and reagent for determining biologically active heparin in plasma27US 4,234,682 ABoehringer Mannheim GmbH · 1980
- Measurement of platelet activities25US 5,266,462 ABaxter Diagnostics Inc. · 1993
- Chromogenic enzyme substrates24US 4,028,318 AA B Kabi · 1977
- Concentrates of coagulation factors II, VII, IX and X, method of their preparation and use24US 5,118,614 ATessek sdruzeni Praha · 1992
- Dynamic continuous flow enzyme reactor23US 4,865,984 AMount Sinai School of Medicine of the City University of New York · 1989